Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지
DOI QR코드

DOI QR Code

Result of Surgical Resection for Pulmonary Metastasis from Urothelial Carcinoma

  • Han, Woo-Sik (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Kwhan-Mien (Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine) ;
  • Park, Joon-Suk (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • Received : 2011.11.09
  • Accepted : 2011.12.14
  • Published : 2012.08.05
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Treatment of pulmonary metastasis from urothelial cell carcinoma has been mostly palliative chemotherapy and the role of pulmonary metastasectomy has not been investigated much. Materials and Methods: This study is a retrospective interim review of pulmonary metastasectomy from urothelial carcinoma at single institution between 1998 and 2010. Overall 16 patients underwent pulmonary metastasectomies. Results: There was no postoperative complication or hospital mortality. Mean hospital stay was 6 days. Overall and disease-free 5-year survival were 65.3% and 37.5%, respectively. Conclusion: In selected patients with pulmonary metastasis from urothelial carcinoma, surgical treatment is feasible and could contribute to long-term survival in selected patients.

Keywords

References

  1. Kanzaki R, Higashiyama M, Fujiwara A, et al. Outcome of surgical resection of pulmonary metastasis from urinary tract transitional cell carcinoma. Interact Cardiovasc Thorac Surg 2010;11:60-4. https://doi.org/10.1510/icvts.2010.236687
  2. Sternberg CN, Yagoda A, Scher HI, et al. Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium. J Urol 1985;133:403-7. https://doi.org/10.1016/S0022-5347(17)48996-8
  3. Rusch VW. Pulmonary metastasectomy: current indications. Chest 1995;107(6 Suppl):322S-31. https://doi.org/10.1378/chest.107.6_Supplement.322S
  4. Montie JE, Clark PE, Eisenberger MA, et al. Bladder cancer. J Natl Compr Canc Netw 2009;7:8-39. https://doi.org/10.6004/jnccn.2009.0002
  5. Park JS, Kim HK, Choi YS, et al. Outcomes after repeated resection for recurrent pulmonary metastases from colorectal cancer. Ann Oncol 2010;21:1285-9. https://doi.org/10.1093/annonc/mdp475
  6. Siefker-Radtke AO, Walsh GL, Pisters LL, et al. Is there a role for surgery in the management of metastatic urothelial cancer? The M. D. Anderson experience. J Urol 2004;171: 145-8. https://doi.org/10.1097/01.ju.0000099823.60465.e6
  7. Abe T, Shinohara N, Harabayashi T, et al. Impact of multimodal treatment on survival in patients with metastatic urothelial cancer. Eur Urol 2007;52:1106-13. https://doi.org/10.1016/j.eururo.2007.02.052
  8. Matsuguma H, Yoshino I, Ito H, et al. Is there a role for pulmonary metastasectomy with a curative intent in patients with metastatic urinary transitional cell carcinoma? Ann Thorac Surg 2011;92:449-53. https://doi.org/10.1016/j.athoracsur.2011.03.097

Cited by

  1. Role of surgical consolidation in metastatic urothelial carcinoma vol.26, pp.6, 2012, https://doi.org/10.1097/mou.0000000000000329
  2. Survival after Metastasectomy for Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis vol.3, pp.2, 2012, https://doi.org/10.3233/blc-170108
  3. Pulmonary metastasis from urothelial carcinoma of the upper urinary tract 29 years after nephrectomy vol.3, pp.None, 2012, https://doi.org/10.1186/s40792-017-0293-3
  4. Predictors of use and overall survival for patients undergoing metastasectomy for bladder cancer in a national cohort vol.27, pp.9, 2020, https://doi.org/10.1111/iju.14288
  5. Stereotactic Body Radiation Therapy in the Management of Oligometastatic and Oligoprogressive Bladder Cancer and Other Urothelial Malignancies vol.33, pp.1, 2012, https://doi.org/10.1016/j.clon.2020.07.008